
Please try another search
Scholastic (SCHL) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended February 2020. This widely-known consensus outlook gives a...
Wall Street expects a year-over-year increase in earnings on higher revenues when Lennar (LEN) reports results for the quarter ended February 2020. While this widely-known consensus outlook is...
Wall Street expects a year-over-year increase in earnings on higher revenues when Duluth Holdings (DLTH) reports results for the quarter ended January 2020. While this widely-known consensus outlook...
Global Eagle Entertainment (ENT) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2019. This widely-known...
Wall Street expects a year-over-year decline in earnings on lower revenues when Aptinyx Inc. (APTX) reports results for the quarter ended December 2019. While this widely-known consensus outlook is...
Wall Street expects a year-over-year decline in earnings on lower revenues when Actuant (EPAC) reports results for the quarter ended February 2020. While this widely-known consensus outlook is...
IMV INC (IMV) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2019. This widely-known consensus outlook gives a...
The Children's Place (PLCE) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended January 2020. This widely-known consensus...
The market expects Translate Bio, Inc. (TBIO) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2019. This widely-known...
PDL BioPharma, Inc. (NASDAQ:PDLI) reported earnings of 2 cents per share (including the impact of stock-based compensation expense) in the fourth quarter of 2019, missing the Zacks Consensus...
Weeks of panic selling given the spread of coronavirus has sent the broader U.S. stock market into bear territory (decline of 20% from the latest peak) in less than a month from peak. This has ended...
Investors might want to bet on Consolidated-Tomoka (CTO), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces...
Check-Cap Ltd. (CHEK) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting...
Investors might want to bet on Avid Technology (AVID), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting...
ASE Technology Hldg (ASX) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings...
Investors might want to bet on Algonquin Power & Utilities (AQN), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings...
Emergent BioSolutions Inc. (NYSE:EBS) announced that it has initiated the development of two product candidates for the treatment and prevention of the novel coronavirus disease, COVID-19. The...